Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,412 | 56,030 | 42,025 | 48,749 | 57,355 |
| Marketable Securities | 119 | 117 | 90 | 84 | 83 |
| Receivables | 929 | 169 | 681 | 589 | 836 |
| TOTAL | $47,010 | $57,850 | $44,240 | $51,751 | $58,627 |
| Non-Current Assets | |||||
| PPE Net | 1,192 | 1,119 | 1,283 | 1,357 | 1,365 |
| Other Non-Current Assets | 270 | 264 | 305 | 285 | 283 |
| TOTAL | $1,462 | $1,383 | $1,588 | $1,642 | $1,648 |
| Total Assets | $48,472 | $59,233 | $45,828 | $53,393 | $60,275 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,210 | 5,694 | 6,877 | 5,999 | 5,785 |
| TOTAL | $5,210 | $5,694 | $6,877 | $5,999 | $5,785 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 502 | 505 | 553 | 462 | 534 |
| TOTAL | $502 | $505 | $553 | $462 | $534 |
| Total Liabilities | $5,712 | $6,199 | $7,430 | $6,461 | $6,319 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,243 | 13,241 | 13,170 | 12,778 | 12,779 |
| Common Shares | 131 | 131 | 128 | 127 | 128 |
| Retained earnings | -91,296 | -80,455 | -70,887 | -61,489 | -54,051 |
| TOTAL | $42,760 | $53,034 | $38,398 | $46,932 | $53,956 |
| Total Liabilities And Equity | $48,472 | $59,233 | $45,828 | $53,393 | $60,275 |